| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |